GSK PLC's ticker is and the CUSIP is 37733W204. A total of 65 filers reported holding GSK PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,597,259 | -10.2% | 41,487 | -0.0% | 0.08% | -16.7% |
| Q1 2024 | $1,778,848 | +14.1% | 41,494 | -1.3% | 0.09% | -4.3% |
| Q4 2023 | $1,558,632 | -0.5% | 42,057 | -2.6% | 0.09% | -19.0% |
| Q3 2023 | $1,565,855 | +0.7% | 43,196 | -1.0% | 0.12% | +90.2% |
| Q2 2023 | $1,554,688 | -0.9% | 43,622 | -1.1% | 0.06% | -56.7% |
| Q1 2023 | $1,569,078 | +4.1% | 44,100 | +2.8% | 0.14% | -13.0% |
| Q4 2022 | $1,507,963 | +16.2% | 42,913 | -2.7% | 0.16% | +165.6% |
| Q3 2022 | $1,298,000 | -38.8% | 44,091 | -9.5% | 0.06% | -38.4% |
| Q2 2022 | $2,122,000 | – | 48,741 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 12,340,190 | $457,759 | 41.36% |
| Eversept Partners, LP | 2,972,954 | $110,177,675 | 9.68% |
| Soleus Capital Management, L.P. | 1,278,540 | $47,382,692 | 5.26% |
| CANTOR FITZGERALD, L. P. | 638,657 | $23,668,628 | 4.86% |
| Sio Capital Management, LLC | 571,391 | $21,175,750 | 4.82% |
| Callodine Capital Management, LP | 450,000 | $16,677,000 | 4.39% |
| EQUITY INVESTMENT CORP | 3,243,259 | $120,195,186 | 3.38% |
| Clean Yield Group | 213,431 | $7,909,753 | 3.33% |
| Robinson Value Management, Ltd. | 128,079 | $4,746,608 | 3.12% |
| Hillman Capital Management, Inc. | 233,386 | $8,649,285 | 2.99% |